Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
5.34
+0.05 (0.95%)
At close: Jul 1, 2026, 4:00 PM EDT
5.40
+0.06 (1.12%)
After-hours: Jul 1, 2026, 7:23 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $745.8 million as of July 1, 2026. Its market cap has increased by 378.31% in one year.
Market Cap
745.80M
Enterprise Value
557.00M
1-Year Change
378.31%
Ranking
Category
Stock Price
$5.34
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $745.80M, an increase of 247.77%. That is a compound annual growth rate of 12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 745.80M | 128.69% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 746.78M |
| Relmada Therapeutics | 732.13M |
| SpyGlass Pharma | 723.83M |
| Rigel Pharmaceuticals | 722.32M |
| Omeros | 717.24M |
| Tenax Therapeutics | 689.74M |
| Eikon Therapeutics | 689.73M |
| 4D Molecular Therapeutics | 673.32M |